Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 11Thoracic 2Other 2Other neoplasm 1Head & Neck 1

Conditions

Lung Neoplasms 3642Carcinoma, Non-Small-Cell Lung 3583Small Cell Lung Carcinoma 576Breast Neoplasms 419Neoplasms 299Adenocarcinoma of Lung 248Colorectal Neoplasms 222Melanoma 201Mesothelioma, Malignant 183Pancreatic Neoplasms 179Prostatic Neoplasms 178Brain Neoplasms 178Head and Neck Neoplasms 172Neoplasm Metastasis 167Ovarian Neoplasms 153Esophageal Neoplasms 152Mesothelioma 145Colonic Neoplasms 140Stomach Neoplasms 139NSCLC 115Pleural Effusion, Malignant 114Carcinoma, Renal Cell 109Urinary Bladder Neoplasms 105Disease 96Sarcoma 85Uterine Cervical Neoplasms 82Thymoma 79Liver Neoplasms 77Motor Activity 75Squamous Cell Carcinoma of Head and Neck 72

Interventions

Immunonutrition Diet 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Esophagitis × Thoracic × Clear all
NCT06840704 2026-04-02

Relief

Hunan Cancer Hospital

Phase 3 Recruiting
121 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Esophagitis, Small Cell Lung Carcinoma

NCT02577393 2020-04-28

Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy

Shandong Cancer Hospital and Institute

Phase 2 Unknown
83 enrolled
Thoracic

Esophagitis, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡